Uren N G, Crake T, Lefroy D C, de Silva R, Davies G J, Maseri A
Division of Cardiology, Hammersmith Hospital, London, United Kingdom.
N Engl J Med. 1994 Jul 28;331(4):222-7. doi: 10.1056/NEJM199407283310402.
The ability of the coronary vascular bed to dilate and thus increase blood flow to the myocardium may be impaired in coronary artery disease, even in regions of myocardium supplied by an angiographically normal coronary artery. If this kind of vasomotor dysfunction was present or accentuated after acute myocardial infarction, it might influence the extent of ischemia and necrosis in areas not directly injured by the infarction.
We studied 13 patients (mean [+/- SD] age, 62 +/- 11 years) with single-vessel coronary artery disease after they had received thrombolytic therapy for myocardial infarction. Using positron-emission tomography (PET) with oxygen-15-labeled water, we measured regional myocardial blood flow under basal conditions and after the intravenous administration of dipyridamole (0.5 mg per kg of body weight over a period of four minutes) 8 +/- 3 days after infarction in all 13 patients (1-week study) and 6 +/- 2 months after infarction in 9 of the 13 (6-month study). On both occasions we measured blood flow both in the infarcted region and in a region of myocardium that was remote from the infarcted region and supplied by a normal artery.
At the one-week PET study, the coronary vasodilator response (the ratio of the myocardial blood flow after the administration of dipyridamole to basal blood flow) was 1.12 +/- 0.50 in the infarct-related artery and 1.53 +/- 0.36 in the remote region (P = 0.015). At the six-month study, the coronary vasodilator response was 1.42 +/- 0.37 in the infarcted region and 2.19 +/- 0.69 in the remote region (P = 0.004 for the comparison with the infarcted region; P = 0.011 for the comparison with the remote region at the one-week study). The value in remote myocardium remained lower than that in similar regions in 10 control patients, who had single-vessel coronary artery disease but no evidence of myocardial infarction (3.17 +/- 0.72; P = 0.009).
After acute myocardial infarction, there is a severe vasodilator abnormality involving not only resistance vessels in infarcted myocardium, but also those in myocardium perfused by normal coronary vessels. This dysfunction may affect the extent of myocardial ischemia and necrosis after coronary occlusion.
在冠状动脉疾病中,冠状动脉血管床扩张从而增加心肌血流的能力可能受损,即使在血管造影显示正常的冠状动脉所供血的心肌区域也是如此。如果这种血管舒缩功能障碍在急性心肌梗死后出现或加重,它可能会影响未直接受梗死损伤区域的缺血和坏死范围。
我们研究了13例单支冠状动脉疾病患者,这些患者在接受心肌梗死溶栓治疗后。使用氧-15标记水的正电子发射断层扫描(PET),我们在所有13例患者梗死8±3天后(1周研究)以及13例中的9例梗死6±2个月后(6个月研究),测量基础状态下以及静脉注射双嘧达莫(0.5mg/kg体重,4分钟内)后的局部心肌血流。在这两种情况下,我们都测量了梗死区域以及远离梗死区域且由正常动脉供血的心肌区域的血流。
在1周PET研究中,梗死相关动脉的冠状动脉扩张反应(双嘧达莫给药后心肌血流与基础血流的比值)为1.12±0.50,远隔区域为1.53±0.36(P = 0.015)。在6个月研究中,梗死区域的冠状动脉扩张反应为1.42±0.37,远隔区域为2.19±0.69(与梗死区域比较,P = 0.004;与1周研究时的远隔区域比较,P = 0.011)。10例单支冠状动脉疾病但无心肌梗死证据的对照患者类似区域的远隔心肌值仍低于这些患者(3.17±0.72;P = 0.009)。
急性心肌梗死后,存在严重的血管扩张异常,不仅累及梗死心肌的阻力血管,还累及由正常冠状动脉灌注的心肌的阻力血管。这种功能障碍可能会影响冠状动脉闭塞后心肌缺血和坏死的范围。